In previous papers1,2) we described the derivation of new macrolide antibiotics using the technique of hybrid biosynthesis. In a series of further trials, we obtained two new compounds by incubating a daunomycin producer Streptomyces sp. KA-464 in the presence of cerulenin with the 16-membered lactone protylonolide, which is a precursor of tylosin biosynthesis and possesses a structure corresponding to the aglycone moiety. This paper describes the isolation and structures of a new macrolide aglycone and a macrolide antibiotic.
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Streptomyces sp. strain KA-464 (KCC U-0202) was cultured in a daunomycin production medium (4% glucose, 1.5% dried yeast, 0.2 NaCI, 0.1% KH2PO4i 0.1% CaCO3, 0.01 MgSO4.7H20, 0.001 % FeSO4.7H20, 0.001 ZnSO4.7H2O, 0.001 % CuSO4.5H20, pH 7.0). To the culture medium 801&g/ml of cerulenine was added initially and at a 24-hour interval to prevent the de novo synthesis of the aglycone moiety, the daunomycinones.
After 72 hours of cultivation, 100 ,ug/ml of protylonolide was added and the cultivation was continued for a further 48 hours. The cultured broth (5 liters) was centrifuged to separate cells. The cells were extracted with one liter of acetone, and the extract was concentrated in vacuo. The residue was combined with the supernatant, which was then extracted with ethyl acetate. The combined organic extracts were evaporated to dryness. sin.3) Compound 3 and chemically obtained 23-hydroxyprotylonolide were identical in mass and NMR spectroscopy as well as thin-layer chromatography. The hydroxylations of protylonolide at 19 and 23 positions by Streptomyces sp. KA-464 are of interest because the former one is not observed in tylosin biosynthesis by S. fradiae, while the latter one is an important reaction occurring after, but not before, the mycaminosylation of protylonolide.4)
This experiment was attempted with the hope of obtaining new daunosaminylated derivatives of protylonolide. However, the desired compounds were not found. It is possible that the daunosamine-binding enzyme is highly specific for the chromophoric aglycone of daunomycin in Streptomyces sp. KA-464.
Compound 3 was further desosaminylated into 23-hydroxy-5-O-desosaminylprotylonolide (4) by a pikromycin-producing strain, Streptomyces sp. AM-7762, in the presence of cerulenin, as was the case with protylonolide converted to 5-O-desosaminylprotylonolide.l
The structure of compound 4 was deduced from the mass, UV and 1H NMR spectral data . The 1H NMR spectrum of 4 showed the appearance of the resonances at o 1.81 (s, N(CH3)2) and 4.23 (d, J=7.5, H-1') by comparison with those of compound 3. Moreover, the El-mass spectrum of 4 showing the molecular ion peak at m/z 567, the aglycone peak at m/z 393, and the sugar peak at m/z 174 (desosamine) strongly indicate that 4 is 23-hydroxy-5-Odesosaminylprotylonolide as shown in Fig. 1 . Compound 4 is a new macrolide antibiotic.
In contrast, the corresponding 19-hydroxyl derivative compound 2 was not converted by strain AM-7762. It is suggested that the attachment of desosamine to the C-5 position is inhibited by the presence of a hydroxyl group at C-19.
Compounds 2 and 3 have no antibiotic activity, but compound 4 was as active in vitro as 5-0-desosaminylprotylonolide (M-4365 G15).
